As shown in Table 1, the patient presented with increased LDH and C-reactive protein (CRP); elevated tumor markers (CA-125, NSE); positivity for plasma EBV-DNA and CMV-DNA; negativity for HIV, hepatitis C and hepatitis B antigen test; and a negative tuberculosis-interferon gamma release assay (TB-IGRA) test. Here, CRP is linked to neoplasm.